Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mefexamide SCHEMBL364170 | 0.99 | CYP3A4 (1.00) | CYP1A2CYP2D6CYP3A4ALDH1A1PTPN1 | |
| Mefexamide SCHEMBL1650022 | 0.97 | CYP1A2 (0.95) | CYP1A2CYP2D6CYP3A4ALDH1A1PTPN1 | |
| Clofexamide SCHEMBL1604514 | 0.87 | CYP1A2 (0.78) | CYP1A2CYP2D6CYP3A4ALDH1A1KDM4E | |
| Clofexamide SCHEMBL365077 | 0.86 | CYP3A4 (0.78) | CYP1A2CYP2D6CYP3A4ALDH1A1KDM4E | |
| SCHEMBL7002893 | 0.84 | CYP1A2 (0.73) | CYP1A2CYP2D6CYP3A4ALDH1A1MAPK1 | |
| Hydrochloric Acid SCHEMBL11539142 | 0.83 | CYP3A4 (0.73) | CYP1A2CYP2D6CYP3A4KDM4ESMN1; SMN2 | |
| SCHEMBL10379993 | 0.79 | LMNA (0.68) | CYP1A2CYP2D6CYP3A4ALDH1A1MAPK1 | |
| Formic Acid SCHEMBL6325576 | 0.78 | CYP1A2 (0.64) | CYP1A2CYP2D6CYP3A4ALDH1A1PTPN1 | |
| SCHEMBL7701481 | 0.78 | CYP1A2 (0.63) | CYP1A2CYP2D6CYP3A4ALDH1A1PTPN1 | |
| SCHEMBL7266793 | 0.77 | CYP1A2 (0.62) | CYP1A2CYP2D6CYP3A4ALDH1A1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 478 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3635130-A1 | PRECISION MEDICINE FOR TREATING AND PREVENTING SUICIDALITY | Indiana University Research and Technology Corporation (US) | 2020-04-15 | — | — | EP | claimed |
| WO-2018209341-A1 | PRECISION MEDICINE FOR TREATING AND PREVENTING SUICIDALITY | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-11-15 | — | — | WO | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-8268352-B2 | Modified release composition for highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-18 | — | — | US | claimed |
| US-8263125-B2 | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-11 | — | — | US | claimed |
| US-8026285-B2 | Control release of biologically active compounds from multi-armed oligomers | BEZWADA BIOMEDICAL, LLC (US) | 2011-09-27 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| US-20090076174-A1 | CONTROL RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | BEZWADA BIOMEDICAL, LLC (US) | 2009-03-19 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| US-6174890-B1 | A SYNERGISTIC BIOLOGICAL, NEUROMETABOLIC AND CELLTROPHIC COMPOSITION COMPRISING ANTIOXIDATIVE AND -CATABOLIC STRESS (METHIONINE),-ANABOLIC DRUGS, VASODILATIVE AND NORMO-LIPIDEMIC DRUGS (NICOTINIC ACID), ENERGOACTIVE AND ANTITOXIC | RIGA DAN (RO) | 2001-01-16 | — | — | US | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-6010715-A | SUSTAINED DRUG RELEASE; MONOLITHIC CARRIER | BERTEK, INC. (US) | 2000-01-04 | — | — | US | claimed |
| EP-0804239-B1 | ANTI-STRESS, ANTI-IMPAIRMENT AND ANTI-AGING DRUG AND PROCESS FOR MANUFACTURING THEREOF | RIGA DAN (RO) | 1999-09-15 | — | — | EP | claimed |
| EP-0563507-B1 | Transdermal patch incorporating a polymer film incorporated with an active agent | BERTEK INC (US) | 1998-05-27 | — | — | EP | claimed |
| EP-0804239-A1 | ANTI-STRESS, ANTI-IMPAIRMENT AND ANTI-AGING DRUG AND PROCESS FOR MANUFACTURING THEREOF | Riga, Dan (RO) | 1997-11-05 | — | — | EP | claimed |
| US-5679373-A | MELT-BLENDING THERMOPLASTIC MATRIX; IMPERMEABLE BACKING; LAMINATION WITHOUT ADHESIVE; CONTROLLED RELEASE | BERTEK, INC. (US) | 1997-10-21 | — | — | US | claimed |
| US-5662926-A | SOLVENT FREE | BERTEK, INC. (US) | 1997-09-02 | — | — | US | claimed |
| WO-1995033486-A1 | ANTI-STRESS, ANTI-IMPAIRMENT AND ANTI-AGING DRUG AND PROCESS FOR MANUFACTURING THEREOF | RIGA DAN (RO) | 1995-12-14 | — | — | WO | claimed |
| EP-0563507-A1 | Transdermal patch incorporating a polymer film incorporated with an active agent | MLI ACQUISITION CORP. II (US) | 1993-10-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076174-A1 | CONTROL RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | MME, CTSA, ALG1 | CYP1A2 3562/4885CYP2D6 3091/4885CYP3A4 2364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.